ArticleLe Mali medical2025
[Variability In Demographic And Clinical Characteristics Of Covid-19 Cases Between The First And Second Waves In Mali].
Article in Le Mali medical, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Since the confirmation of the first case of SARS-CoV-2 in China in December 2019, all countries in the world have been affected by this pandemic. After one (1) year of the pandemic in Mali, two outbreaks were observed. The objective of this study was to characterize the demographic and clinical variability of cases between the two episodes. Materials and Methods: This was a secondary analysis of data from patients with COVID-19 in Mali during the first and the second outbreaks. The anonymous list of all COVID-19 cases confirmed by RT-PCR was used. Pearson's and Student's Chi-square tests were performed with a significance level of 5%. Results: During the study period, 2567 and 4610 people were confirmed positive for SARS-CoV-2 respectively for the first and second epidemics with a similar average age (40.4 years ±17.6 for the first against 39.9 years ± 17.2 for the second). The male sex had a higher proportion in the two outbreaks but different between the waves (69% for the first outbreak and 60% for the second, p < 0.001). The proportion of symptomatic patients was significantly different between the two waves (6.2% for the first wave versus 13.1% for the second wave, p < 0.001). The proportions of cases by age group were significantly similar between the two waves (0-20 years: 10.1% vs 11.3%; 21-40 years: 46.3% vs 45.7%; 41-60 years: 28.2% vs 29.4%; Over 60: 15.4% vs 13.5%; p = 0.063). Death rate was higher in the first episode compared to the second (5.8% versus 4.3%; p = 0.003). Conclusion: SARS-CoV-2 infection in Mali had a significant variation in symptomatology between the two waves, more highlighted in the second. The proportions of age groups of patients with COVID-19 did not vary between the two outbreaks. Death rate was higher in the first wave.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.